Metabolic complications of HIV therapy in children
- 1 September 2004
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (13) , 1753-1768
- https://doi.org/10.1097/00002030-200409030-00004
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal WomenNew England Journal of Medicine, 2004
- Longitudinal Evolution of Bone Mineral Density and Bone Markers in Human Immunodeficiency Virus–Infected IndividualsClinical Infectious Diseases, 2003
- TNF-α promoter region gene polymorphisms in HIV-positive patients with lipodystrophyAIDS, 2002
- XANTHOMAS AND HYPERLIPIDEMIA IN A HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILD RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPYThe Pediatric Infectious Disease Journal, 2002
- Modifiable Dietary Habits and Their Relation to Metabolic Abnormalities in Men and Women with Human Immunodeficiency Virus Infection and Fat RedistributionClinical Infectious Diseases, 2001
- Metabolic Abnormalities in HIV Type 1-Infected Children Treated and Not Treated with Protease InhibitorsAIDS Research and Human Retroviruses, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001
- Impact of Switching from Human Immunodeficiency Virus Type 1 Protease Inhibitors to Efavirenz in Successfully Treated Adults with LipodystrophyClinical Infectious Diseases, 2000
- A Prospective Study of Obesity and Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1990